NCT05617144

Brief Summary

The purpose of this study is to introduce aromatherapy with current pain medication protocols to see if it improves patient satisfaction and reduces pain in hospice care patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable pain

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 7, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 15, 2022

Completed
27 days until next milestone

Study Start

First participant enrolled

December 12, 2022

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2023

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2023

Completed
Last Updated

August 9, 2023

Status Verified

August 1, 2023

Enrollment Period

27 days

First QC Date

November 7, 2022

Last Update Submit

August 7, 2023

Conditions

Pain

Keywords

hospice care

Outcome Measures

Primary Outcomes (1)

  • Patient satisfaction as assessed by the score on the Patient Satisfaction survey

    This survey has 4 questions and each is scored from 1(strongly disagree) to 5(strongly agree) for a maximum score of 20, a higher score indicating more satisfaction

    end of study (7 days after baseline)

Secondary Outcomes (1)

  • Change in pain as assessed by the score on the Wong Baker Face Scale (WBFPS) scale

    Baseline, 2 hours after every aromatherapy administration

Study Arms (1)

Treatment

EXPERIMENTAL
Other: Aromatherapy treatment

Interventions

Aromatherapy treatmentOTHER

60 minutes after pain medication administration primary investigator will turn on the diffuser (manufacture ScentSationals)and administer aromatherapy with a mixture of four drops of lavender and four drops of peppermint for 60 minutes.

Treatment

Eligibility Criteria

Age50 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • currently on hospice at Seasons Assisted Living

You may not qualify if:

  • pain level not 3/10 or higher

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Tamara Blanton, MS,RN

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Student

Study Record Dates

First Submitted

November 7, 2022

First Posted

November 15, 2022

Study Start

December 12, 2022

Primary Completion

January 8, 2023

Study Completion

January 12, 2023

Last Updated

August 9, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations

US(1)